Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The Bronte Amalthea Fund faced a tough -9.07% quarter due to a fierce speculative junk rally that disrupted its long/short correlation. Despite defensive risk-cutting, Bronte remains highly constructive on its core longs, presenting a deep, value-driven case for DSM-Firmenich as an industry-leading F&F compounder.
Full Quick Take
The Bronte Amalthea Fund faced a tough -9.07% quarter due to a fierce speculative junk rally that disrupted its long/short correlation. Despite defensive risk-cutting, Bronte remains highly constructive on its core longs, presenting a deep, value-driven case for DSM-Firmenich as an industry-leading F&F compounder.
Bronte Amalthea Fund returned -0.97% in Q4 2023 and 15.60% YTD, impacted by a severe short squeeze in low-quality North American small caps. Management maintains disciplined risk limits, covering leverage-sensitive shorts while holding high conviction in selected longs like Hibbett.
Full Quick Take
Bronte Amalthea Fund returned -0.97% in Q4 2023 and 15.60% YTD, impacted by a severe short squeeze in low-quality North American small caps. Management maintains disciplined risk limits, covering leverage-sensitive shorts while holding high conviction in selected longs like Hibbett.
